DeSci Protocol Raises New Capital

NanoVita, a decentralized science (DeSci) protocol working on nanotechnology, AI, and real-world health data, has closed its Pre-Series A funding round. The April 9, 2026 announcement named K24 Ventures, LandScape Capital, and WestLabs Venture as participants. The round comes as DeSci projects attract more attention in Web3, with NanoVita building on-chain health research infrastructure.

The project's official channels confirmed the round closed, noting investor support for decentralized health systems. No specific funding amount appeared in primary announcements, and internal records list the event without financial figures. This is notable given recent funding activity, including a Series A round reported separately by some outlets.

NanoVita says the round will help it move faster on personalized health research and data sovereignty. Tweets from the project and investors point to collaboration on Web3 health tools, though operational details depend on how the undisclosed funds get used.

| Fact | Details | |------|---------| | Project | NanoVita | | Sector/Category | Decentralized Science (DeSci) | | Funding Round | Pre-Series A | | Announcement Date | April 9, 2026 | | Amount Raised | Undisclosed | | Valuation | Not specified | | Lead Investor(s) | None designated | | Notable Participants | K24 Ventures, LandScape Capital, WestLabs Venture | | Disclosure Gaps | Raise amount, total raised to date, and specific use of funds not revealed |

Source cross-referencing shows some inconsistencies in round staging. NanoVita's statement and a fundraising digest call this a Pre-Series A, but some news reports describe a Series A around the same time with a $20 million post-money valuation. Internal data logs a Series A on April 6, 2026, and a Seed round on March 31, 2026—both with unknown amounts and overlapping investors like K24 Ventures and LandScape Capital. The rapid progression suggests aggressive fundraising, but the distinctions between rounds remain murky.

The investor group signals targeted interest in DeSci. K24 Ventures publicly congratulated the project, while LandScape Capital and WestLabs Venture were tagged in the announcement.

Three Investors Back Health Data Effort

This funding comes during a busy period for DeSci, where protocols like NanoVita want to open up scientific research through on-chain tools. The project combines AI with nanotechnology to tackle health data problems, potentially letting more people participate in research.

What we know about the round:

• Investor confirmation: K24 Ventures, LandScape Capital, and WestLabs Venture are the backers. No one is named as lead, which differs from some reports on related rounds.
• Stated goals: The funding goes toward decentralized health infrastructure, per the project's announcement. No detailed breakdown was provided.
• Market context: DeSci is seeing more capital flow in. NanoVita's raise fits broader Web3 trends around data ownership and AI.
• Timing: The announcement came alongside reports of a $20 million Series A valuation elsewhere. This Pre-Series A may be part of phased fundraising ahead of token events.

The lack of financial detail makes full assessment difficult, but the investor lineup suggests confidence in NanoVita. Similar DeSci projects have raised undisclosed sums recently, though NanoVita's health-tech focus distinguishes it. Secondary sources mention a possible Token Generation Event on BNB Chain by late April, not directly tied to this round.

Total raised across all stages remains unknown. The quick succession of rounds—Seed, then Series A or Pre-Series A within days—follows a pattern that leaves outside observers guessing.

Bottom line: Investors keep backing DeSci protocols. NanoVita's round shows continued interest in health-focused Web3, even when the numbers stay hidden.